Clincosm LogoSign in Get a demo

JOCONDE: Joint Consultation Between a Neurologist and a Clinical Psychologist

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT05394974
Collaborator
(none)
200
Enrollment
1
Location
24
Anticipated Duration (Months)
8.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Joint consultations appeared a few years ago in routine medical practice, but they are still not widely used and rarely evaluated.

The primary purpose of the study is to evaluate the impact for the patient of the presence of a clinical psychologist during the joint consultation.

The secondary purpose is to evaluate the impact for the patient and for the neurologist of the presence of a clinical psychologist during the joint consultation

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of a Joint Consultation Between a Neurologist and a Clinical Psychologist, Dedicated to Neurodegenerative and/or Neurogenetic Disorders
    Actual Study Start Date :
    Jun 1, 2021
    Anticipated Primary Completion Date :
    Jun 1, 2023
    Anticipated Study Completion Date :
    Jun 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Patient satisfaction after the consultation assessed by 3 questions on a Likert scale [After consultation et 1 to 3 months later]

      5-point Likert scale from which to select a response : Very satisfied. Moderately satisfied. Neither satisfied nor dissatisfied. Moderately dissatisfied. Very dissatisfied.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • patient with a neurodegenerative and/or neurogenetic disease

    • adult patient

    Exclusion Criteria:

    • dementia

    • age <18 years

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service de Neurologie - CHU de Strasbourg - France Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    • Principal Investigator: Mathieu ANHEIM, MD, PhD, Service de Neurologie - CHU de Strasbourg - France

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT05394974
    Other Study ID Numbers:
    • JOCONDE
    First Posted:
    May 27, 2022
    Last Update Posted:
    Jun 13, 2022
    Last Verified:
    May 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Joint neurologist
    psychologist consultation
    neurodegenerative and/or neurogenetic disease
    Additional relevant MeSH terms:
    Neurodegenerative Diseases

    Study Results

    No Results Posted as of Jun 13, 2022